Effects of thymidine and hydroxyurea on the metabolism and cytotoxicity of 1-B-D arabinofuranosylcytosine in highly resistant human leukemia cells.
We have examined the effect of the ribonucleotide reductase inhibitors thymidine (dThd) and hydroxyurea (HU) on the metabolism and cytotoxicity of high concentrations (10 to 100 mumol/L) of cytosine arabinoside (Ara-C) in a deoxycytidine kinase-deficient, highly Ara-C-resistant human promyelocytic leukemic cell subline (HL-60/Ara-C). Administration of dThd or HU (0.5 to 3 mmol/L) in conjunction with high concentrations of Ara-C either sequentially or simultaneously lead to enhanced (and in some cases a supra-additive) inhibition of HL-60/Ara-C suspension culture growth and soft agar colony formation. In addition, exposure of cells to 0.5 mmol/L dThd or HU for 48 hours significantly increased the percentage of HL-60/Ara-C in S-phase. In contrast to previous studies involving low-dose Ara-C administration, we were unable to detect dThd- or HU-mediated increments in Ara-CTP formation in HL-60/Ara-C cells treated with high-dose Ara-C despite reductions in intracellular dCTP pools as great as 65%. However, dThd or HU did increase Ara-C incorporation into newly synthesized DNA. These studies show that administration of dThd or HU in conjunction with high concentrations of Ara-C results in an enhanced antiproliferative effect of Ara-C against Ara-C-resistant leukemic cells deficient in deoxycytidine kinase.
Bhalla
K
K
Division of Hematology/Oncology, Medical University of South Carolina, Charleston 29425.
Swerdlow
P
P
Grant
S
S
D001085:Arabinofuranosylcytosine Triphosphate / Q000378:metabolism; D002453:Cell Cycle / Q000187:drug effects; D002470:Cell Survival / Q000187:drug effects; D003561:Cytarabine / Q000378:metabolism / Q000633:toxicity*; D004247:DNA / Q000378:metabolism; D004351:Drug Resistance; D006801:Humans; D006918:Hydroxyurea / Q000008:administration & dosage*; D066298:In Vitro Techniques; D007951:Leukemia, Myeloid / Q000188:drug therapy*; D013936:Thymidine / Q000008:administration & dosage*; D014407:Tumor Cells, Cultured
D003561:Cytarabine; D001085:Arabinofuranosylcytosine Triphosphate; D004247:DNA; D013936:Thymidine; D006918:Hydroxyurea